Info

Xeragon was founded as a Swiss company specializing in the synthesis of oligoribonucleotides (RNA) in 1997. Xeragon is committed to meeting the needs of RNA scientists in the fields of biopharmaceuticals, diagnostics, therapeutics, and structural studies. We strive to produce high-quality products and deliver the very best in customer care. To keep up with the massively growing demand for synthetic RNA, we decided to move our RNA facility from Switzerland to the United States. Our expanded site in Huntsville, AL, USA has been fully operational since November 2001. Xeragon has a strong background in nucleoside chemistry, enabling us to develop many new methods and technologies. One of our groundbreaking developments is the TOM-Amidites (US Patent 5,986,084), which allow highly efficient chemical synthesis of RNA. Based on our TOM-Chemistry we can now produce RNA's of a higher quality than has ever been possible. We are proud to be able to share this breakthrough in RNA chemistry with our customers, and hope that this will contribute to understanding in this important area of scientific interest. On the 18th of April 2002 Xeragon was acquired by QIAGEN.